MedCity News August 12, 2020
The agreement, which includes 100 million doses of mRNA-1273 and an option to acquire 400 million more, brings the total amount of money the biotech company has received from the federal government for its vaccine efforts to nearly $2.5 billion.
One of the leading companies developing a vaccine against Covid-19 has signed a deal with the federal government to provide up to 500 million doses.
In an announcement Tuesday evening, Cambridge, Massachusetts-based Moderna said the government would award it up to $1.525 billion for an initial 100 million doses of its SARS-CoV-2 vaccine, mRNA-1273, with an option to purchase 400 million more. The new award, along with previous financial commitments, brings the total amount of money the company has raised...
Today's Sponsors
Today's Sponsor